Drug Interactions Workshop

The Drug Interactions Workshop will take place on Thursday, April 2, 2020 from 12:00 to 16:30 in conjunction with the CAPhO Conference 2020

More details about the Workshop to follow. For returning DI Participants, please note that select workshop cases from 2018 and 2019 may be reused at the 2020 workshop.

Details

In small groups, you will work through drug interaction cases with the support of expert facilitators. The cases will be typical of clinically relevant drug interactions you will encounter in oncology pharmacy practice. You and your group will make a series of decisions including interpretation of the drug interaction resource information, prioritization of drug interactions, development of a pharmaceutical care plan including a recommendation, clinical rationale, communication of your plan, and creation of a patient follow up and/or monitoring plan.

Registration

Register Now

Visit the CAPhO 2020 Registration page to register now and for information on the cancellation, refund and substitution policy, methods of payment and other important registration details.

Registration Fees

Workshop registration is open to CAPhO members and non-members. Registration fees are listed below. Fees are quoted in Canadian Dollars (CAD) and exclude 13% Harmonized Sales Tax (HST). Early Bird rates are available until Monday, February 3, 2020. Registrants who pay their registration fee after Monday, February 3, 2020 will be charged the regular registration fee.

  Early Bird Until February 3, 2020 Regular as of February 4, 2020
CAPhO Member $49 $99
Non-Member $149 $199

 

Member registration fees are available to those who have paid their 2019 and renewed their 2020 CAPhO membership. CAPhO Member registrations will be verified and the difference will be charged if a registrant does not qualify for the member's rate.

Workshop Learning Objectives

  • Assessing patient information and evaluating drug interaction resource materials to identify and prioritize drug interactions commonly seen in oncology practice.
  • Integrating critical thinking and “shared decision making” into drug interaction assessment to develop appropriate recommendations and create suitable monitoring plans.
  • Communicating drug interaction(s) with patients and/or care team providers.

Accreditation

The Canadian Council on Continuing Education in Pharmacy (CCCEP) is a national organization established to accredit continuing pharmacy education programs intended to be delivered to pharmacy professionals from more than one province or nationally. CCCEP accreditation is recognized by the pharmacy regulatory authorities in all provinces and territories of Canada.

Information on the number of Continuing Education Credits (CEUs) will be posted once the program is accredited.